PRAX compared with IDYA: revenue, margins and what each company keeps, and the suppliers and customers both name

PRAXPraxis Precision Medicines, Inc.

Mkt capRevenueRevenue

IDYAIDEAYA Biosciences, Inc.

Mkt capRevenueRevenue

Compare

PRAXPraxis Precision Medicines, Inc.

IDYAIDEAYA Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRAX 4

IONSIonis Pharmaceuticalssupplier

—RogConunlistedsupplier

—UCB Biopharma SRLunlistedcustomer

—Tenacia Biotechnology (Shanghai)unlistedcustomer

Shared 0

No shared counterparties.

Only IDYA 5

GILDGileadsupplier

PFEPfizersupplier

—Biocytogenunlistedsupplier

—Les Laboratoires Servier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

customer

1 more · IDYA chain ›

PRAXPraxis Precision Medicines, Inc.

273.51▼−4.34%· post 272.00

Mkt cap$7.6BRevenue$7MQ4 FY24Revenue$9MFY24

IDYAIDEAYA Biosciences, Inc.

31.60▼−1.13%· post 31.60

ClosedNov 2 '26

Mkt cap$3.1BRevenue$9MQ2 FY26Revenue—

Compare

ClosedNov 2 '26

PRAXPraxis Precision Medicines, Inc.

IDYAIDEAYA Biosciences, Inc.

273.51▼−4.34%post 272.00

Price

31.60▼−1.13%post 31.60

$7.6B

Mkt cap

$3.1B

Q4 FY24$7M

Revenue

$9MQ2 FY26

FY24$9M

Revenue

—

PRAX273.51▼−4.34%vsIDYA31.60▼−1.13%ClosedNov 2 '26